Manchester Asthma and Allergy Study - primary prevention of asthma and allergy by allergen avoidance in high risk infants
| ISRCTN | ISRCTN63558189 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN63558189 |
| Protocol serial number | N/A |
| Sponsor | Wythenshawe Hospital (UK) |
| Funders | Asthma UK (UK), Moulton Charitable Trust (UK) |
- Submission date
- 26/09/2005
- Registration date
- 19/10/2005
- Last edited
- 01/08/2017
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Prof Adnan Custovic
Scientific
Scientific
North West Lung Research Centre
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom
| Phone | +44 (0)161 291 2494 |
|---|---|
| adnan.custovic@manchester.ac.uk |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised controlled trial |
| Secondary study design | Randomised controlled trial |
| Study type | Participant information sheet |
| Scientific title | Manchester Asthma and Allergy Study - primary prevention of asthma and allergy by allergen avoidance in high risk infants: a randomised controlled trial |
| Study acronym | MAAS |
| Study objectives | Living in a low allergen environment reduces the risk of primary sensitisation and the development of atopic disease in children at high risk |
| Ethics approval(s) | South Manchester Research Ethics Committee, 24/03/1994, ref: WJP/CMI/ERP/94/032 |
| Health condition(s) or problem(s) studied | Asthma |
| Intervention | House dust mite allergen avoidance versus no intervention. |
| Intervention type | Other |
| Primary outcome measure(s) |
1. Asthma at age 5, 8, 11, and 14 years |
| Key secondary outcome measure(s) |
Wheeze and eczema at age 1, 3, 5, 8, 11 and 14 years |
| Completion date | 01/06/2019 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Sex | All |
| Target sample size at registration | 300 |
| Key inclusion criteria | High-risk children (both parents atopic) of either sex born at Wythenshawe Hospital Manchester and Stepping Hill Hospital Stockport between January 1996 and April 1998 |
| Key exclusion criteria | Premature birth less than 32 weeks gestation |
| Date of first enrolment | 01/09/1995 |
| Date of final enrolment | 01/06/2019 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centre
Wythenshawe Hospital
Manchester
M23 9LT
United Kingdom
M23 9LT
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | results | 21/07/2001 | Yes | No | |
| Results article | environmental control results | 15/08/2004 | Yes | No | |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
Editorial Notes
01/08/2017: internal review